Skip to content

Drug interactions

Ranolazine + Tiotropium-olodaterol

Severity: Moderate

Ranolazine and Tiotropium-olodaterol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ranolazine causes dose-related QT prolongation, and olodaterol may add to proarrhythmic risk through hypokalemia and sympathetic stimulation. The combination warrants attention in patients with other QT risk factors.

What this interaction means in plain words

Ranolazine and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ranolazine belongs to Cardiovascular; Tiotropium-olodaterol belongs to Respiratory.

Evidence level: Low

Why it happens

Additive QT prolongation and beta2-mediated hypokalemia.

What to do

Monitor ECG and electrolytes in patients with cardiac disease. Report palpitations or syncope promptly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ranolazine and Tiotropium-olodaterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ranolazine with Tiotropium-olodaterol?

MediHelp rates the interaction as moderate. Ranolazine and Tiotropium-olodaterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ranolazine causes dose-related QT prolongation, and olodaterol may add to proarrhythmic risk through hypokalemia and sympathetic stimulation. The combination warrants attention in patients with other QT risk factors.

How serious is the interaction between Ranolazine and Tiotropium-olodaterol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and electrolytes in patients with cardiac disease. Report palpitations or syncope promptly.

What other medicines interact with Tiotropium-olodaterol?

MediHelp also lists interactions of Tiotropium-olodaterol with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Tiotropium-olodaterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in